Insights from Canada's 2022 Cannabis Survey

Dec.26.2022
Insights from Canada's 2022 Cannabis Survey
The 2022 Canadian cannabis survey provides insights into Canadians' attitudes and behaviors towards cannabis use, helping inform policy and public education.

The 2022 Canadian Cannabis Survey has provided important insights into Canadians' knowledge, attitudes and behaviours regarding cannabis use.


The Canadian government is collecting data to gain a better understanding of how Canadians perceive and use marijuana. This data will enable better monitoring of the national framework for controlling the production, distribution, sale, and possession of marijuana under the Cannabis Act.


Today, the Canadian Ministry of Health released the results of the 2022 Canadian Cannabis Survey. The Ministry has been conducting this survey annually since 2017, and the 2022 survey marks the sixth round of data collection, which took place from April to June.


The main findings of the 2022 Canadian cannabis study include:


The marijuana usage among teenagers aged 16-19 in the past 12 months has returned to pre-legalization levels in 2021 and 2022, after an increase between 2018 and 2020. Overall, the proportion of daily or almost daily users of marijuana among users, including teenagers aged 16-19 who have problematic or high-risk marijuana use, has remained steady since 2018. The percentage of people classified as "high risk" due to marijuana use has also remained stable since 2018. The proportion of respondents who smoked marijuana has continued to decline since 2018, while the proportion of those who used electronic pens to smoke marijuana has increased since 2021. Smoking marijuana remains the most common way of use, followed by ingestion and using electronic pens or e-cigarettes. Compared to 2021, a larger proportion of respondents reported that their usual marijuana source was from legal sources, with legal storefronts being the most common source since 2019. Compared to 2019, a smaller proportion of people reported illegal storefronts and illegal online sources in 2022. Among marijuana users, the number of people who drove after recent marijuana use decreased between 2018 and 2021 and remained the same in 2022. Over one-fourth of medical marijuana users reported using healthcare professionals' documentation, a proportion that has increased since 2021.


The results of the Canadian marijuana inquiry will be used to provide information for policy and plan development, as well as to assist in targeted public education and awareness campaigns. Survey data will also be helpful in providing information for legislative review of the marijuana bill, led by an independent panel of experts.


This significant survey adds to other national substance use surveys conducted by Health Canada, including the Canadian Alcohol and Drug Use Survey, as well as the Canadian Student Tobacco, Alcohol, and Drug Survey.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

From Partnership to Acquisition: Why KT&G Is Betting on the Global Nicotine Pouch Market
From Partnership to Acquisition: Why KT&G Is Betting on the Global Nicotine Pouch Market
As global competition in the nicotine pouch market accelerates, Korea’s tobacco major KT&G has moved with a “Partnership + Acquisition” strategy, teaming up with Altria to acquire Nordic pouch maker Another Snus Factory (brand “LOOP”). Why deploy capital now, and why take this route? Drawing on company disclosures, regulatory monitoring and on-site observations from InterTabac Dortmund, 2Firsts analyzes KT&G’s strategic calculus and the signals behind this move.
Nov.05
Report: Smoking Rates Remain Unchanged Despite Kazakhstan’s Vape Ban
Report: Smoking Rates Remain Unchanged Despite Kazakhstan’s Vape Ban
According to Exclusive.KZ, Kazakhstan’s Strategy Public Foundation released a study finding that strict tobacco and vape bans have not reduced smoking rates, which remain at 18–20%. The report calls for harm reduction approaches based on international best practices.
Nov.06 by 2FIRSTS.ai
Sarawak Cabinet Approves Gradual Ban on Vape Products to Curb Rising Youth Use
Sarawak Cabinet Approves Gradual Ban on Vape Products to Curb Rising Youth Use
The Sarawak Cabinet has agreed to implement a phased ban on vape products amid growing concern over rising use among youths. Welfare, Community Wellbeing, Women, Family and Childhood Development Minister Datuk Seri Fatimah Abdullah said the move demonstrates the state’s firm commitment to safeguarding young people’s health and future.
Nov.17 by 2FIRSTS.ai
Thailand Seizes Over 42,000 Illegal Vapes Worth USD 340,000
Thailand Seizes Over 42,000 Illegal Vapes Worth USD 340,000
Thai authorities announced the seizure of more than 42,000 smuggled vapes worth approximately THB 10.87 million (USD 340,000).
Dec.12 by 2FIRSTS.ai
Lancashire Police Seize £200K Worth of Illegal Cigarettes and Vapes, Six Arrested
Lancashire Police Seize £200K Worth of Illegal Cigarettes and Vapes, Six Arrested
Lancashire Police seized nearly £200,000 worth of illicit cigarettes and vapes, arrested six suspects, and closed three shops under Operation Wanderstar. Raids on 22 premises across the county also uncovered counterfeit cash, hidden tobacco stashes, and frozen bank accounts linked to suspected money laundering.
Oct.29 by 2FIRSTS.ai
ceshi1111
ceshi1111
Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st
Oct.21